Document is current
Any future updates will be listed below
-
Authors
Scherlinger, Marc https://orcid.org/0000-0002-9453-5895
Kolios, Antonios G. A.
Kyttaris, Vasileios C.
Tsokos, George C. https://orcid.org/0000-0001-9589-2360
- License Information
-
More Information
Article History
Accepted: 4 June 2025
First Online: 17 July 2025
Competing interests
: M.S. is a consultant for Abbvie, Amgen, AstraZeneca, Biogen, BMS, Fresenius, Galapagos, GSK, Innate Pharma, Nordic Pharma, Novartis, Roche, Sandoz. G.C.T. is on the scientific advisory boards of CUGENE, A2 Biotherapeutics, Biolojic and CorEvitas. The other authors declare no additional competing interests.
